Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Using Index Level to adjust risk lets you scale exposure in line with market momentum, maintaining a balanced, rules-based approach.
27,393 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
California Governor Gavin Newsom alleges political targeting by the DOJ, linking a widening probe to his potential pr...
A pure bitcoin-miner fund surged, delivering gains far beyond a wide blockchain ETF as crypto markets rebounded. Here...
Mega-cap tech values are under pressure, and the question on many minds is whether Alphabet, Apple, Microsoft kicked ...
BNB slips on a brief pullback, but longer-term momentum remains constructive as rising moving averages and a quiet re...
Hormel Foods is seeing a noteworthy rally after beating on earnings and reaffirming guidance. This article breaks dow...
XRP surged more than 13% in 24 hours, reclaiming the $1.28 level as sentiment improves and buyers return. On-chain da...
Ethereum bulls face a critical test as ETH approaches a long-standing resistance near the $2,000 mark. This ethereum ...
Bitcoin edges toward the long-term holder cost basis as on-chain data flags growing risk of capitulation. Analysts wa...
Bitcoin breached the $80,000 mark, but market watchers say the rally is not backed by solid demand. The bitcoin marke...
Ethereum prices trended lower in late May, while large holders continued to accumulate ETH. Here’s how on-chain activ...
Enbridge approaches its 52-week high as cash flow strengthens and a robust project backlog fuels optimism. Analysts c...